The Foundation of Innovyra
Innovyra was founded to serve medical device, diagnostics, and life sciences companies that need experienced engineering and program leadership — without the overhead of a full-time hire.
Engagements span the full product lifecycle: embedded program leadership, manufacturing scale-up, cost and scrap reduction, failure investigation, and launch readiness. Every engagement is grounded in the Danaher Business System (DBS) — applying lean methodologies, structured problem-solving, and operating discipline to move initiatives from ad hoc effort to managed programs.
About Andrew Weitsman
Andrew Weitsman is the founder of Innovyra and an engineering and program leader with deep experience in medical device, diagnostics, and life sciences. His background spans embedded program leadership, manufacturing operations, and technical problem-solving — shaped by years of applying DBS principles to real organizational challenges.
Prior to founding Innovyra, Andrew spent 17 years at Cepheid, a global molecular diagnostics leader, rising from engineer to Vice President of Engineering. His work spanned failure investigation, consumables and plastics engineering, and executive program leadership — including overseeing the development of a new instrument and consumable platform from concept to functional prototypes at scale. As Director of Consumables Engineering, he led a 100% increase in plastics manufacturing capacity and a 4x production scale-up during the COVID pandemic while maintaining 95% on-time delivery. He developed and launched a new sample prep consumable platform recognized with an Innovation Award and is a named inventor on the device. His systemic failure investigation work drove first-pass yield from 50% to 95% in six months, saving $1M annually.
Recent consulting engagements include: standing up a structured scrap and cost reduction program at a global diagnostics manufacturer; leading technical failure investigations connected directly to design and process improvement; building the first integrated master schedule for a complex development program at a global medical device company; providing fractional technical advisory to an early-stage diagnostics startup on sample preparation and cartridge design integration; and leading a program through acquisition — running joint planning across two organizations simultaneously while managing concurrent commercial milestones.